CATEGORIES

Healthcare

LATEST

TRENDING

EDITORS CHOICE

Promise and Peril of Instant Health Information Access for Consumers

Apps and AI Help Patients Access in a Blink Their Diagnostic Data: But Lacking Physician Input Fuels Fear

The Future of Post-Acute Care

Too often, patients needing Post Acute Care do not have the critical information they need to carefully assess their options and make informed choices

ZEPOSIA® (ozanimod), a New Oral Treatment for Relapsing Forms of Multiple Sclerosis

ZEPOSIA, a treatment for multiple sclerosis is the first and only approved sphingosine-1-phosphate (S1P) receptor modulator with no genetic test or first dose observation at initiation

Does Pharma Need Independent DNA Oversight?

Our survival as a species could be placed in jeopardy if we don't begin to police treatments that place our DNA in harms way. Oversight is needed.